Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00311597 · ClinicalTrials.gov registry record · Phase 1
Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT00311597 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 48 participants.
The verdict
NCT00311597, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
RATIONALE: Extracranial stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I/II trial is studying the side effects and best dose of extracranial stereotactic radiosurgery and to see how well it works in treating patients with solid tumors.
Interventions
- PROCEDURE Radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2002-06 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00311597
The ClinicalTrials.gov registry entry for NCT00311597 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiosurgery is the first listed.
NCT00311597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00311597 about?
NCT00311597 is a clinical study titled "Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors". RATIONALE: Extracranial stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I/II trial is studying the side effects and best dose of extracranial stereotactic radiosurgery and to see how well it works in treating pat...
What is the current status of trial NCT00311597?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2002-06. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00311597?
The interventions under investigation include: Radiosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00311597?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.